When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
BLPH - Bellerophon advances late-stage study of INOpulse for COVID-19
Bellerophon Therapeutics Inc.
Bellerophon Therapeutics (BLPH+4.8%) announces that the first patient has initiated treatment in Phase 3 study of INOpulse inhaled nitric oxide therapy for COVID-19.
More news on: Bellerophon Therapeutics, Inc., Healthcare stocks news,